227

So08 Vision 2020 in 2020 - Results and remaining challenges
Symposium of the section DOG-international ophthalmology, DOG 2020 Online

So08 Vision 2020 in 2020 - Results and remaining challenges
Symposium of the section DOG-international ophthalmology, DOG 2020 Online

Datum
11.10.2020, 11:30 - 12:15
Sprache
Englisch
Gebühren ab
gebührenfrei
Veranstalter
DOG - Deutsche Ophthalmologische Gesellschaft e.V.
Organisator

INTERPLAN AG
Congress, Meeting & Event Management AG
Landsberger Straße 155
DE - 80687 München
Tel.: +49 (0)89 548 234 35
Tel.: +49 (0)89 548 234 0
Fax: +49 (0)89 548 234 43
Fax: +49 (0)89 548 234 44

More and better treatments as well as preventive care have led to a reduction in the incidence and prevalence of severe visual impairment and blindness in both Germany and globally. However, some of this improvement is outweighed by population ageing, which leads to an increase in the number of persons living with potentially blinding diseases for longer.
  • Basisinformation
    Datum
    11.10.2020, 11:30 - 12:15
    Sprache
    Englisch
    Gebühren ab
    gebührenfrei
    Veranstalter
    DOG - Deutsche Ophthalmologische Gesellschaft e.V.
    Organisator

    INTERPLAN AG
    Congress, Meeting & Event Management AG
    Landsberger Straße 155
    DE - 80687 München
    Tel.: +49 (0)89 548 234 35
    Tel.: +49 (0)89 548 234 0
    Fax: +49 (0)89 548 234 43
    Fax: +49 (0)89 548 234 44

  • Programm

    Organisator/Vorsitzender: Alexander Schuster | Mainz
    Vorsitzender: Rudolf Guthoff | Rostock
    Vorsitzender: Robert P. Finger | Bonn

    Health service provision remains a challenge in many countries with a lack of ophthalmologists or other infrastructural challenges. The goal of VISION 2020 launched in 1999 is to achieve "A world in which nobody is needlessly visually impaired, where those with unavoidable vision loss can achieve their full potential". In the last 20 years, a significant reduction of avoidable visual impairment and blindness has been achieved. One of the pillars has been the successful international cooperation to improve ophthalmic health care in developing countries and to sustain these benefits by local ophthalmologists in cooperation with international eye clinics. This symposium will present and discuss these successes as well as remaining challenges in both Germany and developmental countries, and how they might be addressed in the future.

     

    So08-01
    11:30
    11:36

    VIVION 2020: Origins, aims and achievements in Germany - Developments of visual impairment and health service needs

    Alexander Schuster | Mainz

    So08-02
    11:36
    11:42

    Rehabilitation after sight loss - Upcoming initiatives in Germany

    The German Federation of the Blind and Partially Sighted, together with the German Association for Rehabilitation and other partners, is committed to making rehabilitation after sight loss the standard in Germany. The presentation will report on the wide range of activities for the development of a corresponding concept – from the organisation of the specialists’ conference "Basic Ophthalmological Rehabilitation" and the evaluation of research projects and regional offers through the analysis of care needs, undesirable developments and legal problems in terms of benefit laws, to the development of requirements for the qualification of rehabilitation specialists.

    Andreas Bethke | Berlin

    So08-03
    11:42
    11:48

    Vision 2020 Germany - Success stories and challenges

    Peter Heinz | Schlüsselfeld

    So08-04
    11:48
    11:54

    Achievements and challenges while implementing VISION 2020 in East Africa

    VISION 2020 has left an impact in East Africa in several aspects. Different examples will be presented and discussed.

    Heiko Philippin | Freiburg

    So08-05
    11:54
    12:00

    Vision 2020 international: Implementation of an ophthalmic health care system in the Democratic Republic of the Congo (DRC) , challenges and pitfalls


    Implementation of an Eye health system in DRC as a low-income country needs to assess epidemiological features of eye health in order to determine what strategy has to be used in investing in equipment and materials. Also one should know which diagnostic tool and therapeutic protocol should be taken into account. Otherwise, there will be a waste of finance in buying unnecessary equipments and adopting therapeutic schemes that are not realistic.

    Janvier Kilangalanga | Kinshasa/DRC

    So08-06
    12:00
    12:15

    Discussion

     
  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    120,00 EUR
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    120,00 EUR
    Studenten/-innen
    Gebühren ab
    gebührenfrei
    The full congress is free for students and PhD students.
  • Buchung / Anmeldung

    Registration required. Please contact the organizer for further information.

  • Zertifizierung
    Keine Zertifizierung beantragt

Veranstaltung teilen